Hawkins’ (HWKN) Buy Rating Reaffirmed at BWS Financial

Posted by on Aug 3rd, 2026

Hawkins (NASDAQ:HWKN – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at BWS Financial in a research note issued on Monday,Benzinga reports. They currently have a $200.00 price target on the specialty chemicals company’s stock. BWS Financial’s price target would suggest a potential upside of 52.58% from the company’s current price.

Several other equities research analysts have also recently commented on HWKN. Barclays set a $142.00 price objective on shares of Hawkins and gave the company an “equal weight” rating in a research report on Friday. Weiss Ratings cut Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Hawkins currently has a consensus rating of “Hold” and an average price target of $171.00.

View Our Latest Analysis on Hawkins

Hawkins Trading Up 2.4%

HWKN stock traded up $3.05 during midday trading on Monday, hitting $131.08. 48,343 shares of the company’s stock were exchanged, compared to its average volume of 165,700. Hawkins has a one year low of $117.98 and a one year high of $186.15. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.54 and a current ratio of 2.27. The company has a market cap of $2.74 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 2.31 and a beta of 0.78. The stock’s fifty day moving average price is $148.53 and its 200-day moving average price is $149.87.

Hawkins (NASDAQ:HWKN – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 EPS for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.04). Hawkins had a return on equity of 15.42% and a net margin of 7.29%.The business had revenue of $315.68 million for the quarter, compared to analyst estimates of $313.42 million. Research analysts predict that Hawkins will post 4.27 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Hawkins by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company’s stock valued at $216,754,000 after buying an additional 20,958 shares during the last quarter. State Street Corp raised its holdings in shares of Hawkins by 11.6% in the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock worth $151,642,000 after purchasing an additional 111,318 shares during the period. Wasatch Advisors LP lifted its stake in Hawkins by 31.4% in the fourth quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock valued at $78,477,000 after purchasing an additional 131,850 shares during the last quarter. Geode Capital Management LLC grew its holdings in Hawkins by 2.8% during the fourth quarter. Geode Capital Management LLC now owns 513,535 shares of the specialty chemicals company’s stock valued at $72,965,000 after purchasing an additional 13,828 shares during the period. Finally, Capital World Investors grew its holdings in Hawkins by 34.4% during the fourth quarter. Capital World Investors now owns 477,985 shares of the specialty chemicals company’s stock valued at $67,903,000 after purchasing an additional 122,366 shares during the period. 69.71% of the stock is owned by institutional investors and hedge funds.

Hawkins Company Profile

(Get Free Report)

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

Read More

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.